ClinConnect ClinConnect Logo

Main Menu

Search for Trials
For HCPs
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT04228094

Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD

Launched by UNIVERSITAT DE GIRONA · Jan 10, 2020

Download PDF Apply for Trial

Trial Information

Current as of April 25, 2025

Completed

Keywords

E Health Evidence Based Medicine Machine Learning

ClinConnect Summary

Clinical practice guidelines (CPGP) allow optimizing medical decisions and health care based on the best evidence available. Nevertheless, CPGs have several limitations. First, many GPC are outdated shortly after their publication. Second, CPG recommendations are often not applicable to many patients treated in clinical practice. Most CPGs do not make recommendations for patients with a mild disorder or for complex patients with comorbiditie. Another limitation is that patients involvement in CPGs development is still poor.

We aim to develop and assess TDApp1: an eHealth tool to formulate ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Male and female patients ages 6-65
  • • A diagnosis of DSM-V ADHD based on clinical assessment
  • Exclusion Criteria:
  • • Patients under adequate therapeutic treatment or requiring minor adjustments
  • • Patients lacking an electronic device (mobile phone, tablet,...) with internet access

Trial Officials

Xavier Castells, MD, PhD

Principal Investigator

Universitat de Girona

About Universitat De Girona

The Universitat de Girona (UdG) is a prominent academic institution located in Catalonia, Spain, dedicated to advancing research and education across various disciplines. With a strong emphasis on innovation and interdisciplinary collaboration, UdG actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. The university's research initiatives are supported by a team of experienced professionals and state-of-the-art facilities, fostering an environment conducive to rigorous scientific inquiry and the development of new therapeutic strategies. Through its commitment to excellence, UdG seeks to bridge the gap between research and clinical practice, ultimately benefiting patients and society as a whole.

Locations

Girona, Catalonia, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials